Clinical Trial Update: Busulfan in Treating Children and Adolescents With Refractory CNS Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study of busulfan in children and adolescents with refractory brain and central nervous system tumors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain and Central Nervous System Tumors
• Childhood Germ Cell Tumor

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor | Phase 1 | Status: COMPLETED